CIFALDI, LOREDANA CONCETTA
CIFALDI, LOREDANA CONCETTA
Dipartimento di Scienze cliniche e Medicina Traslazionale
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia
2001-04-01 Cifaldi, L; Quaglino, E; Di Carlo, E; Musiani, P; Spadaro, M; Lollini, P; Wolf, S; Boggio, K; Forni, G; Cavallo, F
ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis
2013-02-01 Galeano, F; Rossetti, C; Tomaselli, S; Cifaldi, L; Lezzerini, M; Pezzullo, M; Boldrini, R; Massimi, L; Di Rocco, C; Locatelli, F; Gallo, A
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM
2008-05-01 Fontana, L; Fiori, M; Albini, S; Cifaldi, L; Giovinazzi, S; Forloni, M; Boldrini, R; Donfrancesco, A; Federici, V; Giacomini, P; Peschle, C; Fruci, D
Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective
2017-12-01 Cifaldi, L; Locatelli, F; Marasco, E; Moretta, L; Pistoia, V
CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses
2010-01-01 Carbone, T; Nasorri, F; Pennino, D; Eyerich, K; Foerster, S; Cifaldi, L; Traidl-Hoffman, C; Behrendt, H; Cavani, A
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
2020-11-01 Melaiu, O; Chierici, M; Lucarini, V; Jurman, G; Conti, L; De Vito, R; Boldrini, R; Cifaldi, L; Castellano, A; Furlanello, C; Barnaba, V; Locatelli, F; Fruci, D
Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I
2009-02-01 Eyerich, K; Cifaldi, L; Notarangelo, L; Porta, F; Notarangelo, L; Mazzolari, E; Fiorini, M; Paradisi, A; Cavani, A
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo
2022-01-01 Bei, R; Benvenuto, M; Focaccetti, C; Fazi, S; Moretti, M; Nardozi, D; Angiolini, V; Ciuffa, S; Cifaldi, L; Carrano, R; Palumbo, C; Miele, Mt; Bei, R; Barillari, G; Manzari, V; De Smaele, E; Modesti, A; Masuelli, L
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma
2023-02-02 Arena, A; Romeo Maria, A; Focaccetti, C; Anastasiadou, E; Trived, P; Cifaldi, L; Gilardini, M; Maria, S; Benedetti, R; Santarelli, R; Gonnella, R; Benvenuto, M; Marchese, C; Masuelli, L; Bei, R; Cirone, M
DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
2019-07-01 Cifaldi, L; Doria, M; Cotugno, N; Zicari, S; Cancrini, C; Palma, P; Rossi, P
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
2023-06-01 Cifaldi, L; Melaiu, O; Giovannoni, R; Benvenuto, M; Focaccetti, C; Nardozi, D; Barillari, G; Bei, R
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study.
2022-07-28 Focaccetti, C; Benvenuto, M; Pighi, C; Vitelli, A; Napolitano, F; Cotugno, N; Fruci, D; Palma, P; Rossi, P; Bei, R; Cifaldi, L
Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer
2020-06-01 Cifaldi, L; Di Santo, J; Olive, D
Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome
2021-01-01 Brandetti, E; Focaccetti, C; Pezzolo, A; Ognibene, M; Folgiero, V; Cotugno, N; Benvenuto, M; Palma, P; Manzari, V; Rossi, P; Fruci, D; Bei, R; Cifaldi, L
ERAAP modulation: A possible novel strategy for cancer immunotherapy?
2012-01-01 Fruci, D; Locatelli, F; Cifaldi, L
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function
2021-01-01 D'Amico, S; D'Alicandro, V; Compagnone, M; Tempora, P; Guida, G; Romania, P; Lucarini, V; Melaiu, O; Falco, M; Algeri, M; Pende, D; Cifaldi, L; Fruci, D
ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors
2015-03-01 Cifaldi, L; Romania, P; Falco, M; Lorenzi, S; Meazza, R; Petrini, S; Andreani, M; Pende, D; Locatelli, F; Fruci, D
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγovercomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
2021-01-01 Caforio, M; Sorino, C; Caruana, I; Weber, G; Camera, A; Cifaldi, L; De Angelis, B; Del Bufalo, F; Vitale, A; Goffredo, Bm; De Vito, R; Fruci, D; Quintarelli, C; Fanciulli, M; Locatelli, F; Folgiero, V
Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma
2012-10-01 Pazzaglia, S; Cifaldi, L; Saran, A; Nobili, V; Fruci, D; Alisi, A
HLA-E and the origin of immunogenic self HLA epitopes
2010-05-01 Lo Monaco, E; Tremante, E; Cifaldi, L; Fruci, D; Giacomini, P
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-apr-2001 | A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia | Cifaldi, L; Quaglino, E; Di Carlo, E; Musiani, P; Spadaro, M; Lollini, P; Wolf, S; Boggio, K; Forni, G; Cavallo, F | Articolo su rivista | |
| 1-feb-2013 | ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis | Galeano, F; Rossetti, C; Tomaselli, S; Cifaldi, L; Lezzerini, M; Pezzullo, M; Boldrini, R; Massimi, L; Di Rocco, C; Locatelli, F; Gallo, A | Articolo su rivista | |
| 1-mag-2008 | Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM | Fontana, L; Fiori, M; Albini, S; Cifaldi, L; Giovinazzi, S; Forloni, M; Boldrini, R; Donfrancesco, A; Federici, V; Giacomini, P; Peschle, C; Fruci, D | Articolo su rivista | |
| 1-dic-2017 | Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective | Cifaldi, L; Locatelli, F; Marasco, E; Moretta, L; Pistoia, V | Articolo su rivista | |
| 1-gen-2010 | CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses | Carbone, T; Nasorri, F; Pennino, D; Eyerich, K; Foerster, S; Cifaldi, L; Traidl-Hoffman, C; Behrendt, H; Cavani, A | Articolo su rivista | |
| 1-nov-2020 | Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma | Melaiu, O; Chierici, M; Lucarini, V; Jurman, G; Conti, L; De Vito, R; Boldrini, R; Cifaldi, L; Castellano, A; Furlanello, C; Barnaba, V; Locatelli, F; Fruci, D | Articolo su rivista | |
| 1-feb-2009 | Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I | Eyerich, K; Cifaldi, L; Notarangelo, L; Porta, F; Notarangelo, L; Mazzolari, E; Fiorini, M; Paradisi, A; Cavani, A | Articolo su rivista | |
| 1-gen-2022 | Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo | Bei, R; Benvenuto, M; Focaccetti, C; Fazi, S; Moretti, M; Nardozi, D; Angiolini, V; Ciuffa, S; Cifaldi, L; Carrano, R; Palumbo, C; Miele, Mt; Bei, R; Barillari, G; Manzari, V; De Smaele, E; Modesti, A; Masuelli, L | Articolo su rivista | |
| 2-feb-2023 | Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma | Arena, A; Romeo Maria, A; Focaccetti, C; Anastasiadou, E; Trived, P; Cifaldi, L; Gilardini, M; Maria, S; Benedetti, R; Santarelli, R; Gonnella, R; Benvenuto, M; Marchese, C; Masuelli, L; Bei, R; Cirone, M | Articolo su rivista | |
| 1-lug-2019 | DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection? | Cifaldi, L; Doria, M; Cotugno, N; Zicari, S; Cancrini, C; Palma, P; Rossi, P | Articolo su rivista | |
| 1-giu-2023 | DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy | Cifaldi, L; Melaiu, O; Giovannoni, R; Benvenuto, M; Focaccetti, C; Nardozi, D; Barillari, G; Bei, R | Articolo su rivista | |
| 28-lug-2022 | DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. | Focaccetti, C; Benvenuto, M; Pighi, C; Vitelli, A; Napolitano, F; Cotugno, N; Fruci, D; Palma, P; Rossi, P; Bei, R; Cifaldi, L | Articolo su rivista | |
| 1-giu-2020 | Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer | Cifaldi, L; Di Santo, J; Olive, D | Articolo su rivista | |
| 1-gen-2021 | Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome | Brandetti, E; Focaccetti, C; Pezzolo, A; Ognibene, M; Folgiero, V; Cotugno, N; Benvenuto, M; Palma, P; Manzari, V; Rossi, P; Fruci, D; Bei, R; Cifaldi, L | Articolo su rivista | |
| 1-gen-2012 | ERAAP modulation: A possible novel strategy for cancer immunotherapy? | Fruci, D; Locatelli, F; Cifaldi, L | Articolo su rivista | |
| 1-gen-2021 | ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function | D'Amico, S; D'Alicandro, V; Compagnone, M; Tempora, P; Guida, G; Romania, P; Lucarini, V; Melaiu, O; Falco, M; Algeri, M; Pende, D; Cifaldi, L; Fruci, D | Articolo su rivista | |
| 1-mar-2015 | ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors | Cifaldi, L; Romania, P; Falco, M; Lorenzi, S; Meazza, R; Petrini, S; Andreani, M; Pende, D; Locatelli, F; Fruci, D | Articolo su rivista | |
| 1-gen-2021 | GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγovercomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape | Caforio, M; Sorino, C; Caruana, I; Weber, G; Camera, A; Cifaldi, L; De Angelis, B; Del Bufalo, F; Vitale, A; Goffredo, Bm; De Vito, R; Fruci, D; Quintarelli, C; Fanciulli, M; Locatelli, F; Folgiero, V | Articolo su rivista | |
| 1-ott-2012 | Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma | Pazzaglia, S; Cifaldi, L; Saran, A; Nobili, V; Fruci, D; Alisi, A | Articolo su rivista | |
| 1-mag-2010 | HLA-E and the origin of immunogenic self HLA epitopes | Lo Monaco, E; Tremante, E; Cifaldi, L; Fruci, D; Giacomini, P | Articolo su rivista |